Skip to content
10-K

Annual Report

BIOMARIN PHARMACEUTICAL INC BMRN

0001048477-26-000004

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 192.32M sh
Shares Diluted FY 2025 · Dec 31, 2025 197.39M sh
Shares Diluted FY 2025 · Dec 31, 2024 196.71M sh
Shares Diluted FY 2025 · Dec 31, 2023 191.6M sh
Capex FY 2025 · Dec 31, 2025 $103.04M
Capex FY 2025 · Dec 31, 2024 $85.42M
Capex FY 2025 · Dec 31, 2023 $96.69M
Operating Cash Flow FY 2025 · Dec 31, 2025 $827.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 $572.84M
Operating Cash Flow FY 2025 · Dec 31, 2023 $159.26M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.31B
Cash And Equivalents FY 2025 · Dec 31, 2024 $942.84M
Stockholders Equity FY 2025 · Dec 31, 2025 $6.09B
Stockholders Equity FY 2025 · Dec 31, 2024 $5.66B
Stockholders Equity FY 2025 · Dec 31, 2023 $4.95B
Stockholders Equity FY 2025 · Dec 31, 2022 $4.6B
Current Liabilities FY 2025 · Dec 31, 2025 $759.03M
Current Liabilities FY 2025 · Dec 31, 2024 $606.99M
Total Liabilities FY 2025 · Dec 31, 2025 $1.51B
Total Liabilities FY 2025 · Dec 31, 2024 $1.33B
Current Assets FY 2025 · Dec 31, 2025 $3.95B
Current Assets FY 2025 · Dec 31, 2024 $3.23B
Total Assets FY 2025 · Dec 31, 2025 $7.59B
Total Assets FY 2025 · Dec 31, 2024 $6.99B
Eps Diluted FY 2025 · Dec 31, 2025 $1.80
Eps Diluted FY 2025 · Dec 31, 2024 $2.21
Eps Diluted FY 2025 · Dec 31, 2023 $0.87
Eps Basic FY 2025 · Dec 31, 2025 $1.82
Eps Basic FY 2025 · Dec 31, 2024 $2.25
Eps Basic FY 2025 · Dec 31, 2023 $0.89
Sga Expense FY 2025 · Dec 31, 2025 $1.15B
Sga Expense FY 2025 · Dec 31, 2024 $1.01B
Sga Expense restated FY 2025 · Dec 31, 2023 $892.41M
Rd Expense FY 2025 · Dec 31, 2025 $921.93M
Rd Expense FY 2025 · Dec 31, 2024 $747.18M
Rd Expense FY 2025 · Dec 31, 2023 $746.77M
Net Income FY 2025 · Dec 31, 2025 $348.9M
Net Income FY 2025 · Dec 31, 2024 $426.86M
Net Income FY 2025 · Dec 31, 2023 $167.65M
Operating Income FY 2025 · Dec 31, 2025 $409.48M
Operating Income FY 2025 · Dec 31, 2024 $484.21M
Operating Income restated FY 2025 · Dec 31, 2023 $185.77M
Cost Of Revenue FY 2025 · Dec 31, 2025 $717.44M
Cost Of Revenue FY 2025 · Dec 31, 2024 $580.24M
Cost Of Revenue restated FY 2025 · Dec 31, 2023 $532.06M
Revenue FY 2025 · Dec 31, 2025 $3.22B
Revenue FY 2025 · Dec 31, 2024 $2.85B
Revenue FY 2025 · Dec 31, 2023 $2.42B